Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOBEREYE OPTOVERA for Measuring PLR Alterations Following Cannabis Use in Healthy Adults
NCT06967051Completed
- Sponsor
- Sobereye
- Start
- May 2025
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Sobereye. Primary endpoint: Difference in change in Pupillary Light Reflex measures between smartphone test and pupillometer at 480 months. Started May 2025; status: completed.
Beyond the preview
Go deeper on NCT06967051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06967051.